﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Sun, 12 Feb 2012 13:48:45--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy New Capsules</title><link>http://www.ashp.org/menu/News/NewsCapsules.aspx</link><description>ASHP Health-System Pharmacy News Capsules</description><language>en-us</language><copyright>Copyright2012 ASHP</copyright><docs>http://cyber.law.harvard.edu/rss/</docs><lastBuildDate>Sun, 12 Feb 2012 13:48:45</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[The Year Ahead for ASHP’s State Government Affairs Advocacy]]></title><link>http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=413</link><description><![CDATA[The issues rising to the forefront in health-system pharmacy for 2012 vary by state, but four concerns top the list of state government affairs advocacy for 2012: Collaborative drug therapy management (CDTM), technician education and certification, health information technology (HIT), and regulation of pharmacies within health systems. Yet there is a common theme: The expansion of the pharmacist&#8217;s role. <br /><br />
According to Karen Noonan, M.A., ASHP&#8217;s director of State Affairs and Grassroots Advocacy, it&#8217;s this advancement of the profession as a whole that makes advocacy at the state level so important. &#8220;State governments &#8211; the legislatures and boards of pharmacy -- define what pharmacists can and cannot do,&#8221; she said. &#8220;The joke is that if you&#8217;ve seen one state, you&#8217;ve seen one state, but states tend to follow each other. For example, Indiana will ask what Illinois is doing. If an issue catches fire in one state, often it will spread out and become an issue in multiple states nearby.&#8221;<br /><br />
To help address these issues, the Society&#8217;s Government Affairs Division partners with state affiliates to reach out to state legislatures and boards of pharmacy. ASHP also serves as a conduit that unites affiliates in a spirit of collaboration. <br /><br />
States confronting similar issues are often at different stages of advocacy and implementation, Noonan said. For example, 43 states allow CDTM to one degree or another. They differ not so much on what pharmacists can do in terms of initiating or modifying treatment, but the practice settings in which pharmacists may do so. Noonan monitors the remaining seven states to determine which ones are trying to establish CDTM and where they might need assistance.<br /><br />
Issues concerning technicians and advanced technician authority (such as &#8220;tech check tech&#8221;) also vary by state, but ASHP position papers offer a blueprint for advocacy and aim for standardized education and certification nationwide—goals that complement and dovetail with the objectives outlined in the Pharmacy Practice Model Initiative (PPMI) for advancing the role of the pharmacist. <br /><br />
&#8220;For pharmacists to practice at the top of their license and fully use their education and skills as experts in safe medication use, the pharmacy technician has to perform his or her job in an optimum manner,&#8221; said Noonan. &#8220;A well-trained, well-regulated tech [technician] workforce enhances our opportunity to advance PPMI. When states rewrite their pharmacy practice acts, that is our opportunity to try to advance our policy positions and maximize the opportunity for ASHP&#8217;s positions to be included.&#8221;<br /><br />
Health information technology&#160;is a hot topic, as well. Remote medication order processing&#160;and computerized prescription order entry&#160;are all regulated, and ASHP watches proposed rules to compare them to the Society&#8217;s official guidelines and positions. &#8220;The questions are: Does a proposed rule comply with our guidelines, does it help ensure safe medication use, and will it be burdensome on the pharmacist?&#8221; said Noonan.<br /><br />
The regulation of pharmacies within a given health system has bubbled to the surface in different ways depending on the state. Such regulations affect multi-campus health systems and hospitals that have pharmacies in different units. <br /><br />
For example, proposed rules may seek to ensure that centralized pharmacies and satellite pharmacies share common electronic files or technology to process orders. &#8220;When you have multiple pharmacies in the same health system, you want to make sure there is no disconnect in communication,&#8221; said Noonan.<br /><br />
To learn more about ASHP&#8217;s advocacy at both the national and state levels, visit the <a href="http://www.ashp.org/menu/Advocacy.aspx">Advocacy </a>section of <a href="http://www.ashp.org">www.ashp.org</a>. <br />]]></description><category>News Capsule</category><guid isPermaLink="false">http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=413</guid><pubDate>Fri, 03 Feb 2012</pubDate></item><item><title><![CDATA[Members Wanted to Serve on ASHP Task Force on Organizational Structure]]></title><link>http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=412</link><description><![CDATA[ASHP is seeking&#160;recommendations for members to serve on the Task Force on Organizational Structure that will begin its work this summer. The task force will review the Society&#8217;s membership structure and governance and make recommendations to the ASHP Board of Directors to ensure that it keeps pace with the changing times, remains relevant and responsive to the needs of members, and continues to be a leader in preparing members for the continuing evolution of practice. 
  The task force will be composed of 12-15 members who will be selected with a goal of bringing to the table a broad array of ideas and perspectives. Ideal candidates will have participated in some element of ASHP governance and policy.
  Members of the task force will review the Society&#8217;s membership structure, including membership classifications, the role of state affiliates, Sections and Forums, as well as the ASHP policy development process. 
  The last Task Force on Organizational Structure was convened in 2000 and resulted in expansion of ASHP&#8217;s Sections and Forums, further integration of Sections and Forums within the governance of ASHP, changes to the House of Delegates, and revision of ASHP&#8217;s principles for state affiliation.Recommendations&#160;must be submitted by Tuesday, February 21, 2012 to be considered.
Read More:
  
    Task Force on Organizational Structure: Call for Recommendations]]></description><category>News Capsule</category><guid isPermaLink="false">http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=412</guid><pubDate>Mon, 30 Jan 2012</pubDate></item><item><title><![CDATA[Shane to Receive 2012 Whitney Award]]></title><link>http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=411</link><description><![CDATA[Rita Shane, Pharm.D., FASHP, FCSHP, Director of Pharmacy Services at Cedars-Sinai in Los Angeles, is the recipient of ASHP&#8217;s 2012 Harvey A.K. Whitney Lecture Award. Dr. Shane is also Assistant Dean, Clinical Pharmacy and Clinical Professor at the University of California, San Francisco College of Pharmacy. 
Throughout her career, Dr. Shane has demonstrated a strong commitment to improving patient safety and the expansion of clinical pharmacy services. At Cedars-Sinai, she has led the creation of a progressive pharmacy practice model that includes patient-centered pharmacists, pharmacist contributions to home care and continuum of care, primary care roles, clinical care pathways, chronic disease management, and specialty pharmacy. 
Dr. Shane also played an influential role in the 13-year effort to allow pharmacy technicians to check pharmacy technicians (Tech-Check-Tech) in acute care settings in California. She served as co-investigator for two research studies and was co-author of the regulatory language approved by the California Board of Pharmacy in 2007.]]></description><category>News Capsule</category><guid isPermaLink="false">http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=411</guid><pubDate>Mon, 23 Jan 2012</pubDate></item><item><title><![CDATA[ASHP Disappointed With Statement On Pharmacists By Family Physicians]]></title><link>http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=410</link><description><![CDATA[The American Academy of Family Physicians (AAFP) recently released a&#160;position paper that seeks to define the role of pharmacists in working with family physicians. The paper, entitled &#8220;Pharmacists,&#8221; expresses a number of views that do not reflect contemporary pharmacy practice or the central tenets of interdisciplinary patient care that are supported by a number of physician organizations and other prominent health care groups. Although the position paper acknowledges the value of the patient care pharmacists provide through collaborative drug therapy management (CDTM), it goes on to state that in the context of prescribing &#8220;the pharmacy professional is in the position to dispense the prescription written by the physician.&#8221; This statement fails to recognize that under CDTM agreements and hospital privileging that pharmacists routinely initiate and modify drug therapy as integrated members of the patient care team.
ASHP plans to work with colleagues in other pharmacy professional associations to respond to this statement and will request a meeting with AAFP leadership to discuss the position paper.]]></description><category>News Capsule</category><guid isPermaLink="false">http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=410</guid><pubDate>Fri, 20 Jan 2012</pubDate></item><item><title><![CDATA[ASHP–APhA Call for Best Practices for Transitions of Care]]></title><link>http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=409</link><description><![CDATA[ASHP and the American Pharmacists Association (APhA) are seeking examples of innovative care models that improve patient outcomes and reduce hospital readmissions by involving pharmacists in medication-related transitions of care. The associations recently launched the Medication Management in Care Transitions Project to provide pharmacists with best practices for care transitions between acute care and home settings.
Submissions of care models should include descriptions of the program, services provided by pharmacists, and outcomes measures. An expert panel will review the submissions to identify key elements for success as well as barriers to implementation.]]></description><category>News Capsule</category><guid isPermaLink="false">http://www.ashp.org/menu/News/NewsCapsules/Article.aspx?Source=Capsule&amp;Type=Rss&amp;Id=409</guid><pubDate>Tue, 03 Jan 2012</pubDate></item></channel></rss>
